Fulgent Genetics agrees to buy StrataDx and assets from Bako Diagnostics for $55.5 million. Learn how this cash deal expands ...
According to Mordor Intelligence, the digital pathology market is valued at USD 2.01 billion in 2026, and is projected to surpass USD 3.2 billion by 2031, growing at a CAGR of 9.90% during the ...
El Monte-based lab testing and pharmaceutical company Fulgent Genetics Inc. last month simultaneously announced a pair of ...
In the most traditional definition of return-on-investment, Sam Terese, former CEO and president of Alverno Laboratories, would say that his company isn’t experiencing a strict apples-to-apples ...
What do you know about the pathologists analyzing your patients' specimens? Are you sure the person signing off on the report is qualified to do so? Some services can analyze and evaluate urologic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback